In a CLP septic mouse model, RvD1 promoted the resolution of inflammation by upregulating SIRT1 expression and inhibiting the activation of STAT3, ERK, p38, and NF-κB in lung tissue, thereby reducing the severity of pulmonary inflammation (Zhuo Y. et al., 2018). The gene discussed is NFKB1; the disease is inflammation.